Prolactinomas resistant to dopamine agonists: insights into pathogenesis and therapy

Curr Opin Obstet Gynecol. 1994 Aug;6(4):393-7. doi: 10.1097/00001703-199408000-00020.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Bromocriptine / therapeutic use*
  • Drug Resistance
  • Female
  • Humans
  • Pituitary Neoplasms / drug therapy*
  • Pituitary Neoplasms / physiopathology
  • Prolactinoma / drug therapy*
  • Prolactinoma / physiopathology

Substances

  • Bromocriptine